Prof. Anat Mirelman awarded Parkinson's Disease Established Scientist Prize

Prof Anat Mirelman awarded the Aufzien Family Center for the Prevention and Treatment of Parkinson's Disease Established Scientist Prize

Prof. Anat Mirelman, PhD, is a Full Professor at the School of Medicine of the Faculty of Medical and Health Sciences and Sagol School of Neuroscience at Tel Aviv University and is the director of the Laboratory for Early Markers of neurodegeneration (LEMON) at the Tel Aviv Medical Center (TLVMC). In her research, she is privileged to address question relating to motor and cognitive function in ageing and disease and mechanisms of neurodegeneration.

In the past 14 years, Prof. Mirelman has lead the ‘Genetics in Parkinson’s disease Project’ at TLVMC. The goal of this project is to identify early markers that could indicate disease processes in patients with Parkinson’s disease (PD) and individuals at risk due to genetic mutations associated with PD. To date, the genetic project includes more than 3000 participants and is considered one of the largest genetic PD cohorts in the world.

Prof. Mirelman’s specific interest is in quantitative, objective measures obtained from wearable sensors and digital technology, and their utility and sensitivity in the prodromal phase of PD. Prof Mirelman is a world renowned leader in this field, a member of the Movement Disorders task force for technology, the chair of the gait advisory committee to Michael J Fox Foundation and the leader of the international gait sub study in the Parkinson’s Progression Marker Initiative.

Prof. Mirelman and her team have published over 180 papers on markers of neurodegeneration and disease progression. LEMON is home to software engineers, neurologists, computational analyst and data scientist, research assistants and several MSc and PhD students.